OBJECTIVE: This study aimed to assess the ocular and metastatic outcomes of @entity1 with @entity66 treated by primary transpupillary thermotherapy (TTT). DESIGN: Retrospective case series. @entity1 : Eight @entity1 presenting @entity66 treated by primary TTT. METHODS: A retrospective chart review was conducted for @entity1 with a newly diagnosed @entity66 treated by at least 3 TTT sessions from 2002 to 2011. Best-corrected visual acuity and lesion dimensions were measured at baseline and during follow-up. Complications were recorded including lesion growth, @entity3 , @entity320 -related mortality, and treatment-related complications. RESULTS: Mean initial thickness was 2.0      0.8  mm. @entity1 had an average of 3.0      0.9 risk factors for lesion growing. Three @entity1 (38%) had lesion growth. Two @entity1 (25%) had severe @entity227 (>1.0 logMAR) directly related to TTT treatment. There were no fatalities due to @entity3 . CONCLUSIONS: Despite careful @entity1 selection and systematic treatment with at least 3 TTT sessions, the use of primary TTT to treat @entity1 with @entity66 with >=  1 risk factor for lesion growth yielded poor local lesion control and the possibility for severe @entity2194 .

Primary transpupillary thermotherapy for XXXX .

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients', 'patient', 'PARTICIPANTS'] @entity227 :: ('MESH:D014786', 'Disease') :: ['visual loss'] @entity2194 :: ('MESH:D005128', 'Disease') :: ['ocular complications'] @entity66 :: ('MESH:D004194', 'Disease') :: ['choroidal indeterminate melanocytic lesions', 'choroidal indeterminate melanocytic lesion'] @entity3 :: ('MESH:D009362', 'Disease') :: ['metastasis'] @entity320 :: ('MESH:D008545', 'Disease') :: ['melanoma']
@entity66 :: (MESH:D004194,Disease) :: ['choroidal indeterminate melanocytic lesions']
